Gelonghui, January 19丨Teyi Pharmaceutical (002728.SZ) was surveyed by a specific target on January 18, 2024. “Are the new varieties launched by the company mainly derived from the original drug approval?” The company replied that the company has sufficient reserves of drug approvals, and later mainly launched the company's original drug approvals. The company expects to launch two to three proprietary Chinese medicines every year, such as skin disease blood poison pills, sugar reduction pills, and Fengliao gastrointestinal health tablets introduced in recent years. At the same time, the company also continues to strengthen brand building, striving to build a “special” brand into a brand with significant market influence, increase the company's market popularity and reputation, and further enhance the company's market influence and core competitiveness.
特一药业(002728.SZ)：预计每年推出两到三个中成药品种
Teyi Pharmaceutical (002728.SZ): It is expected to launch two to three kinds of proprietary Chinese medicines every year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.